Modufolin: Phase I/II started

Isofol began the single-blind, Swedish Phase I/II ISO-CC-002 trial to compare 60 and 200 mg/m 2 IV bolus of Modufolin vs. 60 and 200 mg/m 2 IV bolus of Fusilev levoleucovorin in about 64 patients wit...